Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2025-12-25 @ 4:16 PM
NCT ID: NCT03264157
Description: Includes treatment emergent adverse events
Frequency Threshold: 5
Time Frame: 20 weeks treatment
Study: NCT03264157
Study Brief: Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
BPL HRIG + RabAvert 20 IU/kg dose HRIG + active rabies vaccine HRIG: A 20 IU/kg dose of BPL HRIG will be given on Day 0 via IM injection. RabAvert: A 1.0 ml dose of active vaccine (2.5 IU/ml) will be given IM on 5 occasions: on Days 0, 3, 7, 14, and 28. 0 None 0 81 19 81 View
Comparator HyperRab + RabAvert 20 IU/kg dose HRIG + active rabies vaccine HyperRAB: A 20 IU/kg dose of Comparator HRIG will be given on Day 0 via IM injection. RabAvert: A 1.0 ml dose of active vaccine (2.5 IU/ml) will be given IM on 5 occasions: on Days 0, 3, 7, 14, and 28. 0 None 0 81 19 81 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (Unspecified) View
Vaccination site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View